Please assess the completion status of the following clinical trial:

Trial Title: Optimal Surgical Treatment Of Fulminant Clostridium Difficile Colitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult patients \>18 years of age~2. Able to provide informed consent, or presence of a legally authorized representative able and willing to provide informed consent~3. Candidates for total abdominal colectomy due to severe, complicated FCDC per consulting surgeon and team providing care~4. Subjects must meet criteria for operative management of FCDC (find in detailed protocol)~Exclusion Criteria:~1. Children (\<18 years of age)~2. Allergy or hypersensitivity reaction to study medications: Vancomycin, Metronidazole, GoLytely~3. Intra-operative evidence of colonic perforation~4. Intra-operative evidence of colonic necrosis~5. Pregnancy (this will be ruled out by a urine test at the time of indication for surgery)~6. Prisoners

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- total abdominal colectomy (Type: ACTIVE_COMPARATOR): the standard of care for fulminant clostridium difficile colitis is a total abdominal colectomy
- Ileal diversion and lavage (Type: EXPERIMENTAL): The tested intervention in this trial will be: intraoperative colonic lavage using a high volume polyethylene glycol/electrolyte solution, that will clear Clostridium difficile infection resulting in eradication of FCDC while preserving the colon.

Based on this trial design, predict the completion outcome and termination type (if applicable).